Comparison of AMD proteome vs. retina/RPE proteome changes under oxidative stress. Early biomarkers from our studies are in Italics.
1. Introduction
Age-related macular degeneration (AMD) involves progressive cell death of post-mitotic retinal pigment epithelial (RPE) cells, which adversely affects rod and cone survival. RPE cells are exposed to chronic oxidative stress, including constant exposure to intense light and increased reactive oxygen species (ROS) from mitochondria due to high levels of oxygen consumption. However, understanding how oxidative stress causes phosphoproteomic alterations that initiate death signals in the RPE is elusive. Lack of such knowledge is an important problem, because, without it, acquiring the ability to modulate cellular protection is highly unlikely.
The RPE, located between photoreceptors and choroid, is in a unique position to mediate the transport of nutrients, oxygen, and retinoid from blood to photoreceptors. For continued vision, the RPE is required for retinoid recycling and phagocytosis, which initiates accumulation of retinoid byproducts that eventually leads to apoptosis. Continuous exposure to light causes the RPE to consume a large amount of oxygen in order to complete the complex processes of nutrient transport, phagocytosis, and the visual cycle. It is still not known why the initial retinal degeneration occurs and how the degenerative processes progress as a result of oxidative stress. Adaptation to changes in oxidative environment is critical for the survival of retina and RPE cells. Clinical trials demonstrated a significant reduction toward retinal degeneration upon intake of antioxidants that include lutein, zeaxanthin, zinc, vitamin C, and vitamin E. Oxidation of polyunsaturated fatty acids (PFA) and photosensitizers in the RPE induces reactive oxygen species (ROS) production upon exposure to visible light. Hydrogen peroxide (H2O2) is generated in the RPE during phagocytosis of the photoreceptor outer segment, and it has been used as a direct oxidative-inducing reagent to initiate cellular oxidative stress. Understanding of molecular mechanisms that mediate oxidative stress-induced proteome changes in the RPE may provide insight into the pathogenesis of retinal degeneration. In our study, comparative and differential proteomics have been applied to investigate global changes in the RPE and retina proteome due to oxidative stress induced by light or H2O2.
2. Phosphorylation signaling in the RPE
We have focused on understanding the cell death mechanism of the retina and RPE under oxidative stress [Chung et al., 2009; Lee et al., 2010a; Lee et al., 2010b; Zhang et al., 2010; Lee et al., 2011; Arnouk et al., 2011; Sripathi et al., 2011]. Our studies demonstrated that oxidative stress may trigger induction of anti-apoptotic erythropoietin, JAK2, and BCL-xL, as well as pro-apoptotic caspases. Oxidative stress also influences mitochondrial-nuclear communication by shuttling mitochondrial prohibitin. We examined whether phosphorylations of cytoskeletal and anti-apoptotic proteins, including vimentin, PP2A, and crystalline, regulate the initial protecting mechanism. The cytoskeletal network formed by filamentous proteins determines how retinal and RPE cells respond to their extracellular environmental stimuli that include oxidative stress.
Site-specific phosphorylations of crystalline and vimentin regulate protein interactions through positive or negative feedback mechanisms. The significance of proteomic studies is that they are providing a detailed apoptotic mechanism and new potential AMD-related biomarkers. The global phosphoproteome changes in RPE cells under oxidative stress will help to identify key elements of phosphorylation signaling that serve as a framework of biochemical pathways of AMD progression.
It is a critical question to understand the maintenance mechanism of appropriate phosphorylation signaling under chronic stress conditions. Oxidative stress may influence the expression of genetic risk factors, including complement factor H (CFH). Although the potential importance of protein phosphorylation/dephosphorylation as a therapeutic target has been appreciated, no detailed approach to date has been made targeting biomarkers in phosphoproteome to treat ocular diseases. For example, abnormalities in vimentin phosphorylation have been linked to neurodegenerative diseases, including AMD and Alzheimer’s disease [Madigan et al., 1994; Yen et al, 1983; Yu et al., 1994], but the phosphorylation network mechanism in RPE cells under oxidative stress remains largely elusive.
Regulation of the phosphate on/off switch is a central tool for RPE cells to survive under stress conditions. Unbiased approach to determine phosphorylation sites and kinetics will help to understand the complex apoptotic network and epigenetic controlling mechanism of RPE death. A general proteomic approach that includes protein identification by mass spectrometry has been used routinely for the last decade, however, RPE phosphoproteomics remains challenging due to the complexity, substoichiometry (less than 50% phosphorylated), and kinetics (short vs. long time frame). Understanding phosphorylation in AMD is not clear, because protein phosphorylation is a very dynamic process, while the aging process is slow. Recent animal models exhibiting some of the features of human AMD are available, but most of these models do not represent the full spectrum of pathological changes observed in human AMD. Animal models that mimic the complex and progressive characteristics of AMD are extremely valuable for studying the pathogenesis of AMD and testing different treatment modalities.
Phosphoproteins have been studied using chemical and affinity-based methods [Zhou et al., 2008; Tao et al., 2005]. However, the rapid and dynamic nature of the underlying changes and the low abundance of phosphoproteins reflecting their substoichiometry present challenges to the quantitative study of the phosphoproteome. Thus, the isolation of the phosphoproteome or phosphopeptidome represents a potentially advanced step in this analysis. We introduced a system-wide, unbiased, and high-throughput approach to investigate global phosphoproteome of oxidative stress-induced or aged RPE and retinal cells using phosphoproteome enrichment and labeling method. Phosphoprotein-enriched extracts from human RPE cells under stress were separated by two-dimensional (2D) electrophoresis. Serine, threonine, and tyrosine phosphorylation were visualized by 2D phospho-Western blotting and specific phosphorylation sites were analyzed by tandem mass spectrometry. We examined phosphoproteome changes under oxidative stress
Our results suggest a positive correlation between early biomarkers of phosphoproteome under oxidative stress and RPE proteins from AMD patients. The outcome of the current work is the initial delineation of the underlying physiology of oxidative stress-mediated phosphorylation signaling in RPE apoptosis. In addition, our study suggests a stimulus for understanding oxidative stress-induced cytoskeletal changes and the aggregate formation mechanism by phosphorylations. As a consequence, an effective therapeutic approach and animal model based on the modulation of phosphorylations are expected to result.
Recently, pioneering proteomic profiling studies revealed protein expression changes in human RPE, drusen, and lipofuscin [West et al., 2001; Crabb et al., 2002; Schütt et al., 2007]. Other studies compared native differentiated to cultured dedifferentiated RPE cells [Alge et al., 2003; Alge et al., 2006]. Proteomics proved to be a useful tool in delineating changes in RPE with the progressive stages of AMD [Nordgaard et al., 2006; An et al., 2006; Norgaard et al., 2008], and diabetes [Decanini et al., 2007]. Also, proteomic tools were used to study changes in the vitreous humor associated with diabetic retinopathy [Kim et al., 2007] and retinal proteins in glaucoma model [Tezel et al., 2005]. Since oxidative stress is implicated in the etiology of several RPE diseases that include AMD, identification of molecular mediators and early signaling events under chronic stress is a crucial step for understanding cell death mechanism and retinal degeneration. However, limitations of proteomic approach, including minor proteins with low concentration, hydrophobic membrane proteins, reproducibility, and time and labor demanding processes, exist as huddles to get comprehensive details on the molecular mechanism. Moreover, there is no comprehensive database that could support the analysis of protein phosphorylation in human RPE from the standpoint of spatial and temporal changes.
Phosphorylation of specific amino acids, including serine, threonine, and tyrosine, is a significant modulator of protein function that regulates subcellular localization, protein–protein interaction, conformational change, and signal transduction. Charge changes by phosphorylation creates a protein switch mechanism, allowing reversible phosphorylation to modify intracellular signaling in response to specific microenvironmental and genetic conditions and thereby act as a basic survival tool. However, the rapid and dynamic nature of the underlying changes and the low abundance of phosphoproteins reflecting their substoichiometry present challenges to the quantitative study of the phosphoproteome. The isolation of phosphoproteome or phosphopeptidome represents a potential challenge. Our data and other evidence suggest that phosphorylations are involved in apoptotic or protecting signaling under oxidative stress [Chung et al., 2009; Zhang et al., 2010; Arnouk et al., 2011; Lee et al., 2011; Sripathi et al., 2011].
Proteomic study provides direct evidence and a molecular basis for phosphorylation signaling, cytoskeletal reorganization, and apoptotic mechanisms of AMD [Nordgaard et al., 2006; Crabb et al., 2002; Ethen et al., 2006; An et al., 2006; Warburton et al., 2007]. A detailed proteome analysis of AMD supports our hypothesis that there is a positive correlation between RPE biomarkers under stress and AMD as shown in Table 1.
To address the issue of phosphorylation in cytoskeletal reorganization, we examined morphologic and cytoskeletal changes of RPE cells under oxidative stress
To examine potential markers corresponding cytoskeletal reorganization under oxidative stress, we examined vimentin, an intermediate filament protein shown in both control and AMD drusen [Crabb et al., 2002]. ARPE-19 contains retinal G-protein receptor (RGR) and peropsin as light detecting chromophore. Previous observation of vimentin in RPE cells derived from human choroidal neovascular membranes in AMD, as well as in drusen and melanolipofuscin, supporting our choice of phosphoproteome biomarkers in RPE cells under stress [Schlunck et al., 2002; Crabb et al., 2002; Warburton et al., 2007]. Previously, proteomic analysis of the retina revealed that the expression levels of vimentin and PP2A are significantly increased when C3HeB/FeJ mice (rd1 allele, 12 weeks, photoreceptor degenerated) are exposed under continuous light for 7 days compared to a condition of 12h light/dark cycling exposure [Zhang et al., 2010]. When melatonin is administered to animals while they are exposed to continuous light, the increased levels of vimentin and PP2A return to a normal level. Further, vimentin has been shown to be a target of PP2A that directly binds vimentin and dephosphorylates it. Vimentin is present in all mesenchymal cells, and often used as a differentiation marker. Like other intermediate filaments, vimentin acts to maintain cellular integrity; however, vimentin may play a role in RPE survival by phosphorylation.
ATP synthase β CRABP1 CRALBP Crystallin αA Elf4H GST π HSC 70 HSP 60 HSP 70 Mt HSP 75 Pyruvate kinase VDAC 1 | Annexin 5 Clusterin Complement component 9 Crystallin αB Crystallin βA3 Histone H2A2 Serum albumin TIMP3 Vimentin Vitronectin | Annexin 5 Cytoskeleton-associated protein 4 Desmin EF 1 GST GTPase Rab 14 HSP 70 9B Keratin 7, 18 Lamin A/C MMP-14 Peroxiredoxin 5 Thioredoxin reductase 1 Tubulin VDAC3 | Annexin 5 BUB3 EF2 GST π Guanine binding protein HSP 90 α HSP β1 Lamin A/C Peroxiredoxin 1, 2 Phosphomevalonate kinase Plasminogen activator- inhibitor 1 Prohibitin Pyruvate kinase Retinol binding protein RPE65 Thioredoxin-dependent- peroxide reductase 3 VDAC2 | Actin ATP synthase CRALBP Creatine kinase Crystallin αA Crystallin αB Crystallin βB Crystallin γ G binding protein β1 HSP 70 HSP 90 HSP β1 IRBP Plasminogen Protein kinase 4 Pyruvate kinase RPE65 Tubulin α1B Tubulin β2 |
CRABP Crystallin αA Crystallin αB HSP 60 HSP70 Tubulin α VDAC1 | Annexin 5 Caspase 5 CFB CFH Complement C HSP 47 Laminin MMP2 Prasminogen activator inhibitor 1 | CFB CFH Collagen α Complement C Custerin Galectin 3 BP MMP2 | Annexin 5 ATP synthase Crystallin αB G binding protein HSP 60 HSP 70 Prohibitin RBP 3 RDH 11 RDH 5 RGR RPE65 Tubulin α Tubulin β VDAC 1, 2, 3 Vimentin | Bcl-xL Caspase-3 c-FOS Crystallin αB Crstallin βB Crystallin βS Crystallin γB Crystallin γF EPO EPOR G binding protein Jak2 Peroxiredoxin 2 Peroxiredoxin 6 PP2A Tubulin β Vimentin |
Vimentin is a major component of intermediate filament that spread throughout the cell and serve as signal transducer conveying mechanical and molecular information from cell surface to nucleus and intracellular compartments. Modifications of vimentin are essential reactions of filament dynamics. Changes of vimentin phosphorylation are directed to reorganization of the intermediate filament network and altered function of RPE cells. Hyperphosphorylation of vimentin can disassemble intermediate filament into soluble monomeric form. Our results suggest that vimentin is critically involved in the process of light-induced damage in RPE cells. By reducing the light-induced post-translational modification of vimentin, PP2A may assist to maintain the proper filament network in RPE cells.
Next we tested the hypothesis that oxidative stress may induce protein phosphorylation, including vimentin. Vimentin phosphorylation at S38 is downregulated under stress and is a potential PP2A specific site for dephosphorylation. Phosphorylation at S38 suggests a potential antiapoptotic role when considering increased Bak under oxidative stress. Phosphorylation at S55 under stress condition is upregulated compared to β-actin control. We examined whether normal light- induced phosphoproteome was altered in RPE cells. To investigate RPE phosphoproteome, we used 2D electrophoresis to separate proteins from cells incubated under light (7000 lux) or dark conditions for 1 hour. RPE proteins induced by light were visualized using mass spectrometry-compatible silver staining. MALDI-TOF-TOF mass spectrometry analysis revealed that a large proportion of the proteins up-regulated first and foremost by light in the RPE belong to the crystallin family. Our data demonstrated that crystallins were upregulated under oxidative stress in bovine primary RPE cells. Serine phosphorylation of crystallin was markedly increased in light exposure, as shown by pSer-specific Western blotting. Notably, opposite effects on serine and tyrosine phosphorylation may yield positive or negative regulation with the same stimulus [Taniguchi et al., 2006]. Enzymes associated with phosphorylation or energy metabolism, including Ser/Thr protein kinase 4 (STE20) and ATP synthase, were downregulated under intense light. The most abundant light-induced upregulated phosphoproteins were crystallins, including αA and αB crystallins. Our results may suggest that phosphorylation of crystallin is critical to maintain a chaperone function in RPE cells. Phosphorylations at serine residues were next to proline or near proline. The results of phosphoproteome enrichment experiment were confirmed using an affinity-based phosphopeptide-enrichment strategy. In this experiment, in-solution trypsin digested peptides were concentrated using a metal (Ga+3) based column and analyzed by tandem mass analysis.
Phosphorylation-dependent signaling might differ between tissues, and might reflect the microenvironmental diversity among different tissues, including differences in stress stimuli. Phosphoproteome change is an indication of an early signaling event under oxidative stress conditions in RPE. Increased phosphorylation of crystallins, in particular, might suggest a stress-response role for these proteins in the RPE. Accordingly, crystallin phosphorylation may provide an anti-apoptotic signal to attenuate oxidative stress-induced degenerative pathway as early signaling event. However, accumulated phoshprylated crystallins may lead to pathological mechanism [den Engelsman et al., 2005]. In this context, stress-induced up- or down-regulation of crystallins is known to occur in various diseases or age-related conditions [Nordgaard et al., 2006; Ethen et al., 2006]. The functional relationship between heat-shock proteins and cytoskeletal proteins, such as intermediate filaments, vimentin and actin, is well documented [Clark et al., 2000; Xi et al., 2003]. N-terminal phosphorylation of heat-shock proteins is correlated with the stabilization of cytoskeletal elements.
Our studies support the hypothesis that a progressive accumulation of oxidative damage is a fundamental mechanism involved in RPE cell death. Oxidative stress occurs when free radicals produced in RPE cells are not completely modulated by the appropriate endogenous defense systems. Phospholipids are a major component that can be targeted by excess oxidative stress. Lipid peroxidation plays an important role in initiating and mediating phosphorylation and cell death signaling. Establishing the involvement of lipid changes in phosphorylation signaling has not been an easy task. The lipids of cellular membranes serve roles in controlling the structure and fluidity of the membrane, and as signaling molecules that modifies protein functions. The lipid binding assay demonstrated subcellular communication between mitochondria and the nucleus under oxidative stress. The changes in the expression and localization of p-crystallin and p-vimentin triggered by reactive oxygen species are crucial for RPE integrity.
Recently, crystallin location and function in the retina and RPE have been described [Sakaguchi et al., 2003; Organisciak et al., 2011; Zigler et al., 2011; Sreekumar et al., 2010; Gangalum et al., 2011]. αA- and αB-crystallin are located in the ganglion cell layer and photoreceptor layer, whereas β-crystallin is detected in all nuclear layers of the retina [Xi et al., 2003]. The functional roles of crystallins as chaperones, anti-apoptotic proteins, or signal transducers in the retina have also been described [Xi et al., 2003; Sakaguchi et al., 2003; Kapphahn et al., 2003; Kim et al., 2007]. Phosphorylated αB-crystallin directly interacts with Bax and caspase-3 to suppress their pro-apoptotic action, and thus exerts a cytoprotective effect in the retina [Kim YH et al., 2007]. Light-induced up-regulation of αA-crystallin and increased phosphorylation of αA-crystallin in the aged retina have been reported [Kapphahn et al., 2003]. The specific function of each crystallin, particularly α/β-crystallin in the RPE, is still largely unknown, although levels of αB-crystallin are increased after heat shock and oxidative stress, and αB-crystallin immunoreactivity has been found in both rod outer segments and the RPE after light exposure [Sakaguchi et al., 2003].
3. Early proteome changes under oxidative stress
Two-dimensional differential gel electrophoresis (2-D DIGE) is an advanced proteomic technique that labels minor protein samples with fluorescent dyes before 2-D electrophoresis. It enables accurate analysis of differences in protein concentrations between samples. DIGE method reduces experimental variations and technical errors. It is possible to separate up to three different samples within the same 2-D gel using three different fluorescent molecules. However, there are limitations of DIGE methods also, including covalent modifications on cysteine or lysine.
We used two different biological models that include primary bovine RPE cells and human RPE cell line D407, to uncover differential biosignatures under oxidative stress [Davis et al., 1995]. We employed a combination of proteomic technologies, including sensitive fluorescent labeling and TOF-TOF mass spectrometry analysis with high mass accuracy and low tolerance in the range of 50 ppm (0.05 Dalton). Identified proteins were confirmed by quantitative Western blotting. We observed expression changes of cellular signaling related molecules, including intermediate filament, retinoid metabolism, energy metabolism, and antioxidant proteins in bovine RPE cells. Several intermediate filament components, including neurofilament H, M, L proteins and glial fibrillary acidic protein, were up-regulated in bovine RPE cells. Intermediate filament proteins are cytoskeletal components that form fibrils with an average diameter of 10 nm. Neurofilament H, M, and L proteins are specifically expressed in neurons. Glial fibrillary acidic protein is a biomarker in glial cells. Previous studies showed that environmental changes, such as culture conditions, could induce dedifferentiation of RPE cells and give rise to mesenchymal-like cells.
Proteome changes related to energy metabolism were also observed under oxidative stress in bovine RPE cells. Pyruvate dehydrogenase E1 transforms pyruvate into acetyl-CoA that is used in the citric acid cycle to generate ATP. Pyruvate kinase M1 transfers a phosphate group from phosphoenolpyruvate (PEP) to adenosine diphosphate (ADP), to synthesize ATP and pyruvate. Up-regulation of both enzymes may indicate higher energy consumption to compensate oxidative stress-induced faster turnover of proteins in the RPE.
In RPE D407 cells, several molecular chaperones were altered as a result of H2O2 treatment. Hsp 90α and Hsp β1 exhibit general protective chaperone properties such as preventing unspecific aggregation of non-native proteins. Calreticulin, up-regulated in bovine RPE cells, is a multifunctional protein that binds to Ca2+ and misfolded proteins to export them from the endoplasmic reticulum (ER) to the Golgi apparatus. Elimination of misfolded proteins in the ER affects cellular homeostasis and survival, so chaperone function of heat shock proteins is indispensible under stress conditions.
Retinoid metabolism in primary bovine RPE cells is altered under oxidative stress conditions. Photosensitivity and the steady state of retinoid concentrations are controlled by regeneration of 11-
Antioxidant proteins were upregulated under oxidative stress. Peroxiredoxin is a ubiquitous family of antioxidant enzymes that can be regulated by changes of redox potential in the cell. Thioredoxin-dependent peroxide reductase is an antioxidant enzyme that provides protection mechanism against oxidative stress. It reduces H2O2 by hydride provided by thioredoxin, thioredoxin reductase, and NADPH. Upregulation of antioxidants can regulate redox homeostasis in RPE cells and thus protect cells from oxidative stress-induced damage.
Both biological models using primary bovine RPE cells and immortalized D407 cells have advantages and limitations. We observed differences in protein expressions correlated with oxidative stress in two biological models used in our study, which can be attributed, at least partially, to the inherent differences in two different RPE cell types. It has been reported that cytoskeletal remodeling and cell survival factors are differentially expressed in primary culture and immortalized human RPE cells. Dedifferentiated, immortalized human RPE cells results in down-regulation of specific proteins associated with retinoid metabolism. At the same time, they induce the differential expressions related with cytoskeletal organization, cell shape, migration, and proliferation. Thus, we speculate that two different proteome list in two different systems such as primary bovine vs. immortalized human RPE cells is due to different cell type and not due to species difference or detection system.
Oxidative stress alone is the major risk factor of retinal degeneration compared to genetic risk factors. Furthermore, oxidative stress may influence the expression of genetic risk factor, such as complement factor H (CFH). Cellular processes induced by oxidative stress in RPE cells and the molecular mechanisms under the oxidative stress that contribute to retinal degeneration are not clear at this point. We revealed several expression changes in the RPE proteome that is induced by H2O2 treatment. Targeting early signaling proteins is a useful therapeutic strategy for the treatment of degenerative diseases of the retina and the RPE.
4. Prohibitin as a new oxidative stress biomarker
It is estimated that every ten minutes in the USA someone becomes blind. More than 4 million Americans have age-related macular degeneration (AMD), the most common cause of legal blindness in those older than fifty five. Even though the role of abnormal angiogenesis in the pathogenesis of AMD has been recently established, we still do not know why the macular deteriorates and why AMD progresses. Our proteomic experiments demonstrate that prohibitin is a shuttling protein primarily expressed in mitochondria, however, it translocalizes to the nucleus under oxidative stress. The extent of prohibitin localization in mitochondria inversely correlates with levels of oxidative stress. Our knockdown approach suggests that prohibitin may have the anti-apoptotic function through Bcl-xL and mitochondrial DNA binding mechanisms. Our data further suggests that specific lipid-binding mechanisms involving altered cardiolipin interactions might be the key element to determine prohibitin shuttling between mitochondria and the nucleus. Mitochondrial dysfunction is associated with AMD and our preliminary studies also suggest specific pathophysiological mechanisms involving altered mitochondrial disruption.
Prohibitin is involved in the alternative pathway of complement C activation. However, the regulatory mechanisms are elusive. Prohibitin is subjected to various post-translational modifications under growth factor stimulation and oxidative stress. Prohibitin induces a conformational change that enhances activation of C3.
Prohibitin is originally known as an anti-proliferative protein [McClung et al., 1989]. It is highly conserved from bacteria to human [Asamoto and Cohen SM, 1994], but its function is not clearly understood. Prohibitin was proposed to have a role as a cell cycle inhibitor [Nuell et al, 1991; McClung et al, 1995], a transcriptional regulator [Wang et al, 1999a; Wang et al, 1999b], an inflammatory modulator [Sharma and Qadri, 2004], a plasma membrane receptor [Kolonin et al, 2004], and a mitochondrial chaperone [Nijtmans et al, 2000; Artal-Sanz et al, 2003; Steglich et al, 1999]. Its chaperone function in mitochondria has recently received more attention as a modulator that responds to oxidative stress [Coates et al., 2001]. Prohibitin is involved in apoptosis and aging by stabilizing newly synthesized respiratory enzymes [Bourges et al, 2004; Nijtmans et al, 2002], however, its presence and function in the eye has never been studied. Our studies demonstrate that prohibitin is a novel protein that shuttles between mitochondria and the nucleus as an anti-apoptotic chaperone as well as a transcriptional regulator under oxidative stress [Arnouk, et al., 2011; Lee et al., 2010; Srinivas et al., 2011].
Prohibitin undergoes phosphorylation at multiple residues under various cellular condition or in response to various stimuli. Phosphorylation of prohibitin facilitate its interaction with SH2 domain containing phospho tyrosine phosphatases Shp1 and Shp2. In a separate study, prohibitin was identified as a substrate for Akt and it has been shown that Akt induced prohibitin phosphorylation at threonine258. While these studies have clearly shown that prohibitin is phosphorylated at multiple residues, however, conditions under which these residues are phosphorylated and functional consequences are not clear. Prohibitin binding proteins were apoptosis related (Bcl-2 like protein), cholesterol homeostasis (PI4K5, diacylglycerol kinase, apolipoprotein B48 receptor, VLDLR), nucleotide binding proteins (guanine exchange factor, endonuclease, cell cycle regulator) and a complement component (Table 2).
5. Anti-apoptotic prohibitin function in mitochondria
We performed loss of function studies using prohibitin-specific small interfering RNA (siRNA) to demonstrate an increase of apoptotic signaling when prohibitin was knockdown. We tested two siRNA constructs that inhibit prohibitin expression compared to a control siRNA that has a random sequence. A solvent vehicle was used as the second negative control also. We chose conditions when prohibitin expressions were reduced by 80-90% compared to random sequence control. We examined whether prohibitin knockdown activates pro-apoptotic AIF, BAK, and caspases. Prohibitin knockdown may control other anti-apoptotic molecules also. Indeed, pro-apoptotic AIF, caspase-9, and BAK increased under prohibitin knockdown condition whereas anti-apoptotic Bcl-xL decreased. Also we examined decreased prohibitin condition cleaves poly (ADP ribose) polymerase (PARP) as a
Vav-1 guanine exchange factor | 98 kDa/6.2 | proto-oncogene |
ATP binding cassette 4 | 66 kDa/6.9 | regulator of cAMP level |
DEAD box 32 | 84 kDa/5.0 | RNA helicase |
epithelial cell transforming 2 | 104 kDa/7.5 | oncogene |
guanine exchange factor | 119 kDa/5.9 | activation of GTPases |
Transglutaminase | 93 kDa/6.5 | protein aggregation |
phosphoinositol-4-phosphate 5 kinase | 45 kDa/9.6 | epithelial cell morphology actin polymerization |
Nei Endonuclease VIII like protein 1 | 37 kDa/9.2 | DNA excision repair |
Bcl-2 like protein 14 | 37 kDa/7.7 | apoptosis facilitator |
calpastatin | 76 kDa/4.9 | calpain inhibitor |
complement component C6 | 105 kDa/6.7 | membrane complex |
cell cycle regulator Mat89Bb homolog | 80 kDa/6.2 | nucleus-centrosome coupling |
diacylglycerol kinase zeta | 103 kDa/9.8 | phosphatidic acid synthesis |
Apolipoportein B48 receptor-like | 109 kDa/4.4 | carrying cholesterol to |
very low density lipoprotein receptor | 93 kDa/4.7 | regulator of cholesterol levels |
pro-apoptotic marker because PARP cleavage is an early marker of caspase activation. Transfection of siRNA of prohibitin into ARPE-19 cells resulted in increased cleavage of PARP which represents that an apoptotic signal is induced when prohibitin is down-regulated.
Next we examined whether caspases are also activated as essential markers in apoptosis. The activation of caspase-9, one of the upstream regulators in apoptosis, showed early apoptotic signaling under prohibitin knockdown condition. Our results suggest that knockdown of prohibitin increases caspase-dependent apoptotic signaling. This data implies that prohibitin may act as an anti-apoptotic protein in mitochondria by forming a functional complex with other apoptotic proteins. Prohibitin concentration is inversely correlated with the initiation of apoptosis. Then we asked whether decreased prohibitin disrupts the filamentous reticular network of mitochondria resulting in fragmented mitochondria. Immunocytochemical analysis showed that prohibitin knockdown led to accumulation of fragmented mitochondria. Then we asked whether expression and localization of prohibitin is altered under stress condition.
Emerging evidence suggest that oxidative stress and associated local upregulation of alternative pathway of complement may play a critical role in the progression of AMD. However, the link between oxidative stress. Altered prohibitin function may be a connecting link between oxidative stress and complement activation in AMD. Our studies demonstrate that prohibitin expression in the RPE is altered under oxidative stress
We have been actively seeking early molecular signaling events under oxidative stress in the retina and RPE using a proteomics and metabolomics approach to identify new biomarkers. This approach demonstrated that prohibitin is involved in oxidative stress signaling
We examined the cellular localization of prohibitin which is a controversial question. Confluent ARPE19 cells were treated with 200 µM H2O2 for 24 hrs and prohibitin localization in response to oxidative stress was investigated using immunocytochemistry. Subcellular organelles and prohibitin were visualized by DAPI (nuclear DNA, blue, 369/460 nm absorbance/emission), MitoTracker (mitochondria, red, 578/599 nm absorbance/emission), and Alexa-488 (prohibitin, green, 495/519 nm absorbance/emission), by taking three color fluorescent images every hour. This kinetic assay confirmed that the signaling pathway was involved in prohibitin transit to the nucleus from mitochondria. H2O2 treated cells showed nuclear translocalization of prohibitin, whereas untreated cells showed localization in mitochondria. After 8 hrs, prohibitin showed an accumulation in the nucleus as compared to the control group. After 24 hrs, more nuclear prohibitin was observed and prohibitin didn’t show as much colocalization with mitochondria.
To answer whether prohibitin is modified under stress condition, we tested the correlation between oxidative stress and the ratio of soluble vs. membrane-binding prohibitin. Because prohibitin may exist in both detergent-resistant and soluble fractions, we tried to separate prohibitins by longer running time SDS-PAGE. Soluble prohibitin in the cytosolic fraction moved faster when compared to membrane-bound mitochondrial and microsomal prohibitin. Detergent-resistant, membrane-binding prohibitin showed slightly higher molecular weight when compared to soluble prohibitin. We found that the ratio of soluble prohibitin to membrane binding prohibitin decreased under oxidative stress. Under stress condition, soluble prohibitin decreased and membrane-binding prohibitin increased. To answer how long this trend would last under oxidative stress, we performed a kinetic assay under oxidative stress. After 6 hrs, the soluble prohibitin level returned to its control level. It is possible that the membrane-binding and soluble form exists in different subcellular organelles, so we next examined the subcellular localization of prohibitin by fractionation.
Membrane-binding prohibitin showed slightly higher molecular weight when compared to soluble prohibitin. We examined the correlation between oxidative stress and soluble vs. membrane-binding prohibitin and found that the ratio of soluble prohibitin to membrane binding prohibitin decreased under oxidative stress. Soluble prohibitin decreased and membrane-binding prohibitin increased under stress condition. Then we tested how long this trend would last under oxidative stress. After 6 hrs, the soluble prohibitin level returned to its control level. It is possible that the membrane-binding and soluble form exists in different subcellular organelles, so we examined whether prohibitin binds a mitochondrial specific phospholipid, cardiolipin.
6. Prohibitin binds cardiolipin under oxidative stress
We asked whether prohibitin localization could be controlled by membrane lipid binding. We speculated that the localization and trafficking of prohibitin might be determined by mitochondrial-specific lipid such as cardiolipin. Lipid interaction assay demonstrated that mitochondrial prohibitin has a strong affinity at low cardiolipin concentration whereas nuclear prohibitin showed a much weaker affinity to cardiolipin, interacting at higher concentrations. Lipid analysis in ARPE-19 cells by mass spectrometry demonstrated that cardiolipin concentration decreased 20-70% under 200 μM H2O2.
This result suggests that membrane lipid and modification may determine prohibitin localization under oxidative stress. When cardiolipin concentration is low under oxidative stress, prohibitin moves to the nucleus. Then we tested whether prohibitin may have preference toward specific lipids when prohibitin is a limiting factor. Under normal condition, prohibitin from ARPE-19 cells demonstrated a strong interaction with phosphatidylinositol 3,4,5 triphosphate (PIP3), PIP2, PIP, and 3-sulfogalactosylceramide, but not with cardiolipin. Lipid binding affinity changed dramatically under oxidative stress. Prohibitin under stress showed a strong affinity toward cardiolipin, phosphatidylserine, and phosphatidic acid. This observation led us to conclude that prohibitin has an affinity towards negatively charged phospholipids, especially cardiolipin under oxidative stress.
To examine prohibitin response under oxidative stress in detail, we then examined protein expression level changes
Our previous
In mitochondrial fraction, prohibitin showed 32 kDa molecular weight and pI=5.6 as expected. Prohibitin was more acidic in the nucleus showing pI=5.3, possibly due to post-translational modifications such as phosphorylation. Mass spectrometry analysis revealed that S101 and S151 sites are phosphorylated. Cytosolic prohibitin showed very basic spots of pI=6-7 and higher molecular weight as shown in the box.
As each subcellular prohibitin showed different pI values in 2D electrophoresis, we examined potential post-translational modifications, including phosphorylation. Each fraction was separated by electrophoresis and prohibitin was visualized by Western blot using prohibitin and phospho-serine (pSer) antibodies. Only the nuclear fraction showed phosphorylated prohibitin shown by pSer Western blot. Mitochondrial, cytosolic, and microsomal prohibitin did not show phosphorylation. To confirm this data, we performed native gel electrophoresis and received the same result.
7. Neuroprotective erythropoietin (EPO)
Apoptosis is the primary mechanism that results in the abnormal death of photoreceptors, retinal ganglion cells (RGC), or retinal pigment epithelial cells (RPE) in degenerative retinal diseases, including age-related macular degeneration (AMD), retinitis pigmentosa (RP), and glaucoma. Light insults result in increased production of reactive oxygen and nitrogen species that include hydrogen peroxide and nitric oxide, which are involved in an early event of retinal degeneration. In response to intense or constant light triggers, neuroprotective proteins provide an antiapoptotic effect to protect retinal and retinal pigment epithelial (RPE) cells, however, the mechanisms remain elusive. Thus there is a critical need for understanding the intrinsic neuroprotective mechanisms that prevents apoptotic cell death. Our studies suggest that potential degeneration signaling may result from expression changes and phosphorylations of key proteins of EPO downstream. EPO down-regulates caspases and intense light up-regulates caspases, which imply that depleting EPO is one of the major light effects that can cause changes in protein expression through anti-apoptotic mechanisms.
We demonstrated that the retinal expression of EPO and subsequent phosphorylation of Jak2 and Stat3 are tightly linked to the circadian clock after oxidative stress and in anticipation of daily light onset. Our data suggest that the neuroprotective effects of EPO might be involved the regulation of apoptotic signaling molecules, including Bcl-xL, and caspase-3. In the RPE, NO was proposed as a secondary messenger in phagocytosis. Interdependent regulation of NO and EPO has not been examined, even though recent studies imply potential interactions of NO-EPO through the Hif1a pathway.
Retinal injury due to light occurs through oxidative mechanisms. Recently we demonstrated that the recycling reactions of 11-
We found that nitric oxide (NO) was generated in RPE cells under light exposure. NO is related to the inhibition of ischemic injury and plays a key role in the delayed cell death following transient retinal ischemia. Thus, NO is proposed as a neuroprotective molecule or neurotoxic reagent based on its local concentration. In the RPE, NO was proposed as a second messenger in phagocytosis. Interdependent regulation of nitric oxide and EPO has not been examined, even though recent studies imply potential interactions of NO-EPO through either HIF1a or arginine metabolism. Appropriate levels of nitric oxide (NO) may cause up-regulation of EPO/EPOR in RPE and thereby assist in limiting retinal degeneration.
EPO has been extensively studied for its neuroprotective role for the past 10 years, but the regulation mechanisms have not been understood at the molecular level [Brines and Cerami, 2005; Calapai et al., 2000; Jelkmann 2007; Kanaan et al., 2006; Kawakami et al., 2001; Li et al., 2007; Mauer 1965; Miyake et al., 1977; Yamaji et al., 1996; Zhong et al., 2007]. Previous approaches using the
The
Erythropoietin (EPO) is an oxygen-dependent hematopoietic cytokine that stimulates the proliferation, differentiation, and survival of erythroid progenitor cells. EPO protects cells from neuronal damage, including experimental central nervous system models of hypoxic and ischemic insults [Jelkmann and Metzen, 1996; Jelkmann, 2005]. Oxygen dependent mechanisms are derived from models such as traumatic brain injury [Brines et al., 2000], spinal cord injury [Celik et al., 2002], Parkinson’s disease [Kanaan et al., 2006], excitotoxicity [Kawakami et al., 2001; Morishita et al., 1997], oxidative stress [Calapai et al., 2000] and chemical neurotoxicity [Genc et al., 2001]. EPO can protect retinal ganglion cells (RGCs) from degeneration induced by acute ischemia reperfusion injury [Liu XT et al., 2006] and axotomy injury [Weishaupt et al., 2004].
EPO promotes survival of RGCs in a glaucoma mouse model [Zhong et al., 2007], and stimulates neurogenesis and post-stroke recovery [Tsai et al., 2006].
However, controversial discussions of EPO in retinal neuroprotection exist. Understanding EPO function in pathological angiogenesis is critical to timing for intervention [Chen et al., 2008]. Our studies demonstrated that EPO and EPOR interactions represent an important retinal shield from physiologic and pathologic light-induced oxidative injury.
To test the hypothesis that EPO is regulated by light
Our data demonstrated that the circadian organization of retinal EPO and EPOR elaboration is a potentially effective endogenous physiologic strategy for retinal protection from light-induced, oxygen-mediated damage. These findings are consistent with documented circadian regulation of the full range of oxidative damage protecting enzymes or antioxidants, including glutathione (GSH/GSSG).
Then, we tested the hypothesis that oxidative stress, including intense light, hypoxia, and hyperoxia, may induce EPO response in the retina
We treated EPO (50-200 U) on rat retinal cells and human RPE cells
As an endpoint analysis, we performed a cell viability assay using a rat retina and human primary RPE cell culture treated with H2O2 as an oxidative stress model for a control experiment. At a concentration of 20 μM or higher for 3 hrs, H2O2 exerted significant toxicity to retinal cell cultures. H2O2-induced retinal cell death was reduced to 40, 46, or 43 %, respectively, by 30 min pretreatment of 50 units of EPO with 40 μM H2O2 for 6, 12, and 24 hrs. In contrast, only a mild protective effect (15%) was observed in the RPE exposed to H2O2 by EPO treatment in 24 hrs.
To see the protective effect in the RPE, a high dose of EPO (up to 200 U) was required, and was found mildly toxic to the RPE cells. Phase-contrast photomicrographs showed that no significant cell death occurred in sham-washed control or treated human RPE cells with 400 μM H2O2 for 12 h. Cell viability was assessed by the amount of lactate dehydrogenase (LDH) release measured from the medium of RPE cultures exposed to H2O2 for 3, 6, 12, and 24 hrs.
EPO is a powerful cytoprotective protein against apoptosis. However, elevated levels of EPO are found in the vitreous due to proliferative diabetic retinopathy [Katsura et al., 2005; Watanabe et al., 2005]. In addition, high dose of EPO increased the risk of cardiovascular disease and tumor growth [Singh et al., 2006; Bohlius et al., 2006].
These studies suggest a role of EPO in pathological retinal angiogenesis. The effects of EPO on angiogenesis are not well understood and the role of EPO in vascular stability is not clear. Understanding the functional role of EPO on angiogenesis is beneficial to patients with diabetic retinopathy (DR) and retinopathy of prematurity (ROP). EPO has been known to promote endothelial cell proliferation and vessel growth, however, the influence of EPO on apoptotic signaling and retinopathy is beginning to be understood. To determine the effects of EPO on vessel growth, we explored downstream regulators of EPO under normal physiological condition. VEGFR1 and angiotensin I/II as two major angiogenic factors were examined. VEGFR1 in the retina and angiotensin I/II in RPE increased after EPO treatment (100 U) in 6-12 h, respectively.
Our study suggests that the role of EPO in the development of initial vessel loss via VEGF/VEGFR/angiotensin signaling. This signaling is important in understanding retinal vessel loss that is initiated prior to neovascularization. The initial vessel loss determines the severity of neovascularization. VEGF was downregulated upon EPO knockdown in RPE cells, which may suggest that EPO and VEGF expression is regulated in parallel, and they may interact directly or indirectly.
EPO induces the proangiogenic phenotype in rat retina and human RPE cells. Addition of EPO correlates with the progression of VEGFR and AngiotensinI/II, which suggests that EPO might be an endogenous stimulant of vessel growth during retinal angiogenesis and in the development of neovascularization. Possibly, EPO mediates the renin-angiotensin system (RAS) which may promote neovascularization through local changes in blood flow and production of VEGF. EPO is considered as a proinflammatory agent since it triggers the expression of angiotensin I/II, which may act as an inflammatory agent by enhancing vascular permeability through VEGF. We examined whether the EPO-dependent pathway is up-regulated or down-regulated in various oxygen-imbalance conditions. Along with increased levels of EPO after light exposure, levels of rhodopsin in retinal cells increased as early as 15 min after 5000 lux light exposure in a time-dependent manner. RPE65 cleavage increased after 15 min exposure to 5000 lux light in the RPE. Immunoblots for Bcl-xL and c-Fos showed that the neuroprotective effects of EPO may involve upregulation of these early markers in stress-induced condition. Anti-apoptotic Bcl-xL and c-Fos were also up-regulated in the light. EPO-mediated neuroprotective effects attribute to interaction with Jak2, Bcl-xL, and c-Fos. Other downstream regulators such as Stat3 might be required for anti-apoptotic Bcl-xL induction as shown in the motor neuron [Schweizer et al, 2002]. Jak2 and Stat3 phosphorylations in retinal and RPE cells increased under hypoxia, hyperoxia, and light exposure.
Proangiogenic protein VEGF is up-regulated under hypoxic conditions in the retina and the RPE. Our data demonstrated that EPO and VEGF expressions are regulated in parallel, and they may interact directly or indirectly. We will test our hypothesis that pro-angiogenic signaling of VEGF regulated by EPO.
EPO and EPOR had a similar pattern of distribution in both neurons and astrocytes. Within 3 hrs after exposure to hypoxia, expression of EPO and EPOR in various retinal cells increased. The number of co-localized cells with EPO/EPOR with retinal cell markers also increased in 1% O2 hypoxic condition. Relative levels of EPO mRNA were determined by real time-PCR in hypoxia. An elevated EPO level was detected after exposure of primary retinal cells to hypoxia (1% O2) with 6-fold up-regulation after 12 h. We observed intense light induced up-regulation of c-Fos, Bcl-xL, thioredoxin pJak2, pSTAT3 in early passage of human RPE cells. Rat retina cells under bright light up-regulated pJak2, EPO, and EPOR in an hour. pJak2 and pStat3 in the RPE increased in hypoxic condition (1% O2). Phosphorylation of Jak2 and Stat3 was confirmed as shown by phospho-Western blot. As an upstream regulator of EPO, HIF-1a was examined. HIF-1a increased in light, hyperoxic, and hypoxic conditions.
8. Cytoskeletal reorganization under oxidative stress
Not only intense light but also constant moderate light may trigger induction of anti-apoptotic Bcl-xL, EPO, and pro-apoptotic caspases. We postulate that light may induce post-translational modifications of target proteins. Previously, we identified that serine/threonine protein phosphatase 2A (PP2A) is induced and modified under constant light
To our knowledge, protein nitration mechanism under various oxidative environmental conditions, including intense light and continuous light, has never been studied in retinal cell cultures, RPE cells, or mouse model system. Our contribution here is expected to be a detailed understanding of how PP2A modification of a subunit is regulated by endogenous signaling molecule, nitric oxide (NO). PP2A and vimentin might be critically involved in the process of light-induced retinal and RPE cell damage. It is expected that what is learned will be equally applicable to anti-apoptotic mechanism. In addition, the research will be of significance because what is learned will contribute to broader understanding of how other phosphatase activity can be modulated as an approach to therapy.
Although the potential importance of protein dephosphorylation as a therapeutic target has been appreciated, no detailed approach has been made targeting PP2A. Abnormalities in PP2A activity and concentrations have been linked to neurodegenerative diseases, including Alzheimer’s and Parkinson’s. The mechanism by which PP2A activity is regulated under oxidative stress remains largely elusive. Despite recent advances on structural investigation of PP2A, comprehensive understanding of dephosphorylation mechanism is far from complete.
Our data suggests that PP2A and vimentin are critically involved in the process of light-induced damage in the retina and RPE. By modulation of light-induced post-translational modifications of PP2A, vimentin may assist in maintaining the proper filament network in Müller cells, which subsequently supports neuronal survival and architecture in the retina. Dephosphorylation switch by tyrosine nitration will provide new targets for therapeutic interactions in apoptosis-mediated disorders.
Light-induced photoreceptor damage depends on the functional visual cycle, a biochemical regeneration of 11-
The expression levels of a scaffold subunit of PP2Aa and vimentin are significantly increased when mice are exposed under continuous light for 7 days compared to control in rd 1 degeneration model [Zhang et al., 2010]. When melatonin is administered to animals while they are exposed to continuous light, the levels of vimentin and PP2A return to a normal level. Vimentin is a PP2A target of direct dephosphorylation. Vimentin is present in all mesenchymal cells and often used as a differentiation marker. Like other intermediate filaments, vimentin acts to maintain cellular integrity; further, vimentin may play a role in adhesion, migration, and cellular survival in the RPE. We demonstrated that bright light up-regulates pro-apoptotic signaling by cleavage of caspase-3 and Bcl-xL [Chung et al., 2009].
Exposure to continuous light at intensities ordinarily encountered during daytime causes retinal degeneration. How constant light induces retinal degeneration remains unknown, although potential mechanisms have been proposed, including defects in rhodopsin regeneration, accumulation of free radicals, and a continuous low level of Ca2+ resulting from an excessively active phototransduction cascade.
We examined the impact of constant light-exposed proteome changes
PP2Aa | Y169 | nitration |
Actin b cytoplasmic 1 | T186 | phosphorylation |
Tubulin b 2B | Y50, Y51, T55 | phosphorylation |
Tubulin b 5 | Y159 | nitration |
Tubulin b 5 | S168, S172 | phosphorylation |
Vimentin | Y38, S325 ,S412, S420 | phosphorylation |
Vimentin is a major component of intermediate filament that spread throughout the cell and serve as signal transducer conveying mechanical and molecular information from cell surface to nucleus and intracellular compartments. Neuronal cytoskeleton is a potential therapeutic target in neurodegenerative diseases. Vimentin phosphorylations were further analyzed by 2D electrophoresis with narrow range of pI for higher resolution. Vimentin phosphorylation decreased under constant light
Hyperphosphorylation of vimentin can disassemble intermediate filament into soluble monomeric form. Müller cells are the major glial cells in the retina and play crucial roles in maintaining neuroretinal architecture and support neuronal survival. Our results suggest that vimentin and Müller cells might be critically involved in the process of light-induced damage in the retina. By reducing the light-induced post-translational modification of vimentin, PP2A may assist to maintain the proper filament network in Müller cells, which subsequently supports neuronal survival and architecture in the retina. To test changes of PP2A and cytoskeletal proteins in RPE
A decrease in cytoskeletal protein turnover leads to the accumulation of large aggregates of actin and tubulin, which triggers an increase in the levels of reactive oxygen species (ROS). Dynamic and differential changes in the cytoskeleton occur in apoptotic cellular processes. Thus, we ask how phosphorylation of vimentin regulates cytoskeletal dynamics and cell survival under stress conditions in RPE. We hypothesize that the modifications of PP2A and vimentin influence the cytoskeletal network through interplay with other cytoskeletal proteins. A stabilized vimentin may act as an antiapoptotic agent when cells are under stress.
Methylation and phosphorylation of PP2A catalytic c subunit are evolutionary conserved mechanisms that critically control the PP2A holoenzyme assembly and substrate specificity. However, interplay of PP2A nitration and phosphorylation that may control subunit binding has never been studied.
Regulation of tyrosine nitration could be a potential intervention of early stage light-induced ocular diseases. We postulate, on the basis of our data, that modifications of PP2A and vimentin influence the cytoskeletal network through interplay with other cytoskeletal proteins, including tubulin and actin. A positive correlation between the levels of PP2A and vimentin under light-induced stress suggests that cytoskeletal dynamics is regulated by dephosphorylation of vimentin as a PP2A substrate.
To examine PP2A and cytoskeletal proteins under oxidative stress, we examined light-induced cytoskeletal changes using ARPE-19 cells. ARPE-19 contains retinal G-protein receptors (RGR) and peropsin as light detecting chromophores. The assembly of the major cytoskeleton proteins, including vimentin, tubulin and actin, are highly interdependent. Thus, we investigated β-tubulin and the interplay of vimentin dynamics with microtubules under light. Tubulin is a highly concentrated building block (10–20 μm) of microtubules. β-tubulin is aggregated as shown by particles (white arrow) under intense light (Figure 5). b-tubulin is colocalized with mitochondria in dark, but changed localization under light condition. Confluent ARPE-19 cells were treated with either dark or 7000 lux white light for 2 hr. Mitochondria was stained by 100 nM MitoTracker Orange. β-tubulin was visualized by Alexa 488 secondary antibody and the nucleus was stained by DAPI. To follow vimentin-tubulin interaction changes in light, we analyzed tubulin polymerization rates and vimentin-tubulin colocalization. β-tubulin is a major component of the microtubule and also an essential component of the cytoskeleton. They play a critical role in cell division and cell motility. Our results demonstrated that actin filament also aggregated in cytosol under intense light condition in RPE. In the dark, β-actin is localized in cytosol, but in light β-actin is aggregated outside of mitochondria. Light-induced modification of cytoskeletal proteins may imply a potential regulatory mechanism in apoptosis. Direct interaction between vimentin and actin has been observed [Esue et al., 2006]. The tail domain of vimentin intermediate filaments interacts directly with actin, which may regulate cytoskeletal crosstalk. Morphologic change and cytoskeletal reorganization of RPE cells were observed under oxidative stress
9. The visual cycle
The steady-state of retinoid concentration and photosensitivity are controlled by the biosynthetic pathway leading to 11-
RPE is susceptible to oxidative stress due to its high oxygen consumption, the generation of reactive oxygen species (ROS), the presence of a high percentage of unsaturated fatty acids, and exposure to light [Bok, 1993; Strauss, 2005]. RPE65, a peripheral membrane protein of RPE cells, is thought to be an all-
RPE contains anti-apoptotic and neuroprotective factors to support retina survival and maintenance. With aging, an imbalance occurs between ROS production and the capacity for detoxification resulting in the accumulation of ROS and the diminution of mitochondrial respiratory function. These ROS may contribute to the development of eye diseases such as cataract [Spector, 1995], uveitis [Satici et al, 2003; Bosch-Morell et al, 2002], glaucoma [Osborne et al, 1999; Babizhayev et al, 1989], retinopathy of prematurity [Dani et al, 2004; Head 1999], AMD [Beatty et al, 2000; Spraul 1996], and diabetic retinopathy [Kowluru et al, 1994]. Thus, understanding the mechanism of elevated ROS during aerobic metabolism and the resulting oxidative stress is important to the treatment of eye diseases. Under sub-lethal conditions of oxidative stress, mitochondrial respiratory function is impaired by electron leakage [Yakes and Van Houten, 1997; Melov et al, 1999] leading to decreased ATP production. Moreover, elevated ROS induce mutations in mitochondrial DNA, oxidative damage to cellular macromolecules forming cross-linked aggregates, and accumulation of damaged proteins [Grune et al, 1997].
Several mutations in the
In 1989, Rando proposed that RPE membranes might be the energy source for isomerization of all-
Recently, we found that levels of RPE65 and RPE45, as a truncated form of RPE65, increased after short-term exposure to intense or constant light in the human RPE cultures [Chung et al., 2009; Lee et al., 2010a]. Also, the level of RPE45 is present in cells exposed to high oxidative stress
Interestingly, C57BL/6 mice have a gene polymorphism (M450) associated with lower level of RPE65 expression and reduced light-damage sensitivity. We observed a higher threshold for RPE45 appearance when RPE cells were exposed to light and oxidative stress simultaneously compared to cells under oxidative stress alone, suggesting that the protective mechanism may exist to maintain RPE65 concentration under light-induced oxidative stress.
We examined the appearance of RPE45 and RPE20 fragments
To address the functional significance of RPE45, we tested the ability of the RPE45 fragment to bind biotinylated all-
A defect in RPE65 can trigger a remodeling of the retina that may disrupt photoreceptor homeostasis and induce apoptosis cascades leading to retinal degeneration [Shang and Taylor, 2004]. Light influences the translocation of transducin, arrestin, and recoverin; tyrosinase-mediated light adaptation, and the synthesis of retinoic acid and melatonin. Our studies indicate that oxidative stress and light exposure can influence the visual cycle. The dose-dependent induction of RPE45, a fragment of RPE65 generated in response to H2O2 or light exposure by a specific caspase-mediated cleavage suggests that RPE45 is a potential signaling molecule of oxidative stress- and light-induced apoptosis [Chung et al., 2009; Lee et al., 2010a]. Proteolysis after stress is an important signal transduction pathway mediated by caspases, presenilin, and amyloid precursor protein, which can lead to neurodegenerative disorder or inflammation [Martinon and Tschopp 2004; Shi 2004; Haass and Strooper 1999]. We also observed up-regulation of NF-kB and amyloid beta in the RPE under oxidative stress. RPE65 is known as highly uveitogenic and antigenic protein implying involvement in pathogenic autoimmune diseases in the eye [Ham et al, 2002]. Changes in RPE65 expression are also seen
In nature, all biochemical reactions are dependent on the coupling of the free energy changes of phosphate- (ATP), thio- (CoA), and oxy- (membrane lipids) esters. For all-
We suggest that RPE45 may result from degradation of RPE65 by ROS-induced proteases [Budihardjo et al., 1999; Santoro et al., 1998]. It is likely that RPE cells have a defense mechanism against oxidative stress and we therefore investigated the expression of anti-apoptotic factors in oxidative stress. We found that anti-apoptotic Bcl-xL was increased under intense light [Chung et al., 2009]. The positive correlation between the expression of these anti-apoptotic factors and RPE65 under oxidative stress suggests that RPE65 may have a positive role in apoptotic signaling. Proteolysis after stress is an important signal transduction mediated by caspases, presenilin, and amyloid precursor protein, which can lead to neurological disorder or inflammation in the retina and brain [Martinon and Tschopp 2004, Shi 2004, Haass and Strooper 1999]. RPE65 is known as highly uveitogenic protein implying involvement in pathogenic autoimmune disease in the eye [Ham et al. 2002]. Under oxidative stress, aged cells increase the number of mitochondria and induce anti-oxidant genes [Sitte et al, 2000; Lee et al, 2000]. Retinoid map in the retina and the RPE is shown in Figure 3. Potential target sites to regulate retinoid and A2E are shown in red bars.
10. Conclusion
While the end point of apoptosis is well established, there is still a large gap between knowledge of early biochemical events and the end stage of age-related macular degeneration (AMD). Proteome changes under oxidative stress have been studied in regard to the pathogenesis of AMD [Yang et al 2006]. Understanding the molecular mechanism of proteomic signaling will provide a novel insight into apoptotic processes in AMD. It is expected that the knowledge will be equally applicable for understanding the lipid-mediated cell death mechanism.
Light-induced retinal degeneration in animal model occurs only when the visual cycle is functional. Regeneration of 11-
Our proteomic approaches to understand RPE cell death under stress conditions demonstrate that: 1) crystallins are upregulated and hyperphosphorylated. 2) neuroprotective erythropoietin and subsequent JAK2 phosphorylations are tightly linked to a specific time after oxidative stress and in anticipation of daily light onset. 3) early signaling molecules, including mitochondrial prohibitin, changes their expression, subcellular localization, phosphorylation, and lipid interaction under oxidative stress. 4) relative lipid compositions, including phosphatidylcholine and cholesterol, are altered under oxidative stress. 5) oxidative stress leads to cytoskeletal reorganization through site-specific vimentin phosphorylations that regulate intermediate filaments, resulting in nonfilamentous particles.
AMD is characterized in its early stages by the presence of extracellular deposits, known as drusen, that accumulates between the basal surface of the RPE and Bruch’s membrane. During the past decade, compelling evidence has emerged implicating the immune system and the complement system in particular in drusen biogenesis and AMD. A number of the proteins detected in drusen are either complement components or related molecules. Despite these significant advances, the identity of the molecules responsible for triggering activation of the complement cascade, as well as the downstream molecular interactions that promote AMD pathology, remain elusive. Our proteomics studies will provide new insight into the underlying mechanisms involved in the development and progression of AMD and further elucidate the relationship between various risk facotors, including oxidative stress and complemnt activation. Such information are critical for the development of more effective therapeutic strategies for the treatment of retinal degeneration that includes AMD.
References
- 1.
Alcazar O. Hawkridge A. M. Collier T. S. Cousins S. W. Bhattacharya S. K. Muddiman D. C. ME Marin-Castano Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells. Mol Cell Proteomics.2009 8 2201 11 - 2.
Alge C. S. Suppmann S. Priglinger S. G. AS Neubauer May. CA Hauck S. Welge-Lussen U. Ueffing M. Kampik A. Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest Ophthalmol Vis.Sci.2003 44 3629 3641 - 3.
Alge C. S. Hauck S. M. Priglinger S. G. Kampik A. Ueffing M. Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival. J Proteome Res.2006 5 862 878 - 4.
An E. Lu X. Flippin J. Devaney J. M. Halligan B. Hoffman E. P. Strunnikova N. Csaky K. Hathout Y. Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J Proteome Res.2006 5 2599 2610 - 5.
Arnouk H. Lee H. Zhang R. Chung H. Hunt R. C. Jahng W. J. Early biosignature of oxidative stress in the retinal pigment epithelium J Proteomics.2011 74 254 261 - 6.
The mitochondrial prohibitin complex is essential for embryonic viability and germline function in Caenorhabditis elegans. J Biol Chem.Artal-Sanz M. Tsang W. Y. Willems E. M. Grivell L. A. BD Lemire der Spek. H. Nijtmans L. G. 2003 278 32091 9 - 7.
Asamoto M. Cohen S. M. Prohibitin gene is overexpressed but not mutated in rat bladder carcinomas and cell lines Cancer Lett.1994 83 201 7 - 8.
Babizhayev MA, Bunin AYa. Lipid peroxidation in open-angle glaucoma. Acta Ophthalmol (Copenh).1989 67 371 7 - 9.
Bavik C. O. Erikson U. Allen R. A. Peterson P. A. Identification and partial characterization of a retinal pigment epithelial membrane receptor for plasma retinol-binding protein. J. Biol. Chem.1991 266 14978 14985 - 10.
Bavik C. O. Busch C. Eriksson U. Characterization of a plasma retinol-binding protein membrane receptor expressed in the retinal pigment epithelium. J. Biol. Chem.1992 267 23035 23042 - 11.
The retinal pigment epithelium membrane receptor for plasma retinol-binding protein. J. Biol. Chem.Bavik C. O. Levy F. Hellman U. Wernstedt C. Eriksson U. 1993 268 20540 20546 - 12.
Beatty S. Koh H. Phil M. Henson D. Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol.2000 45 115 34 - 13.
Bellamy WT, Alberts DS, Dorr RT. 1988 Daily variation in non-protein sulfhydryl levels of human bone marrow. Eur J Cancer Clin Oncol24 1759 1762 - 14.
Böcker-Meffert S, Rosenstiel P, Röhl C, Warneke N, Held-Feindt J, Sievers J, Lucius R. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest Ophthalmol Vis Sci 2002;43:2021-2026. - 15.
Bohlius J. Wilson J. Seidenfeld J. Piper M. Schwarzer G. Sandercock J. Trelle S. Weingart O. Bayliss S. Djulbegovic B. Bennett C. L. Langensiepen S. Hyde C. Engert A. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients J Natl Cancer Inst.2006 98 10 708 14 - 16.
Bok D. The retinal pigment epithelium: a versatile partner in vision. J. Cell Sci.1993 Sup17 189 195 - 17.
Bok D. Ruiz A. Yaron O. Jahng W. J. Ray A. Xue L. Rando R. R. Purification and characterization of a transmembrane domain-deleted form of lecithin retinol acyltransferase. 2003 42 20 6090 8 - 18.
Bosch-Morell F. Romá J. Marín N. Romero B. Rodriguez-Galietero A. Johnsen-Soriano S. Díaz-Llopis M. Romero F. J. Role of oxygen and nitrogen species in experimental uveitis: anti-inflammatory activity of the synthetic antioxidant ebselen. Free Radic Biol Med.2002 33 669 75 - 19.
Structural organization of mitochondrial human complex I: role of the ND4 and ND5 mitochondria-encoded subunits and interaction with prohibitin. Biochem J.Bourges I. Ramus C. Mousson de Camaret. B. Beugnot R. Remacle C. Cardol P. Hofhaus G. Issartel J. P. 2004 383 491 499 - 20.
Brines M. Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci2005 6 484 494 - 21.
Brines M. L. Ghezzi P. Keenan S. Agnello D. de Lanerolle N. C. Cerami C. Itri L. M. Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc Natl Acad Sci USA2000 97 10526 10531 - 22.
Budihardjo I. Oliver H. Lutter M. Luo X. Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol.1999 15 269 290 - 23.
Calapai G. Marciano M. C. Corica F. Allegra A. Parisi A. Frisina N. Caputi A. P. Buemi M. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol2000 401 349 356 - 24.
Celik M. Gökmen N. Erbayraktar S. Akhisaroglu M. Konakc S. Ulukus C. Genc S. Genc K. Sagiroglu E. Cerami A. Brines M. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Proc Natl Acad Sci USA2002 99 2258 2263 - 25.
Chen J. Connor K. M. Aderman C. M. Smith L. E. Erythropoietin deficiency decreases vascular stability in mice J Clin Invest.2008 118 2 526 33 - 26.
Chen Y. Moiseyev G. Takahashi Y. Ma J.-x Impacts of two point mutations of RPE65 from Leber’s congenital amaurosis on the stability, subcellular localization and isomerohydrolase activity of RPE65 FEBS Lett.2006 580 4200 4204 - 27.
Chung H. Lee H. Lamoke F. Hrushesky W. J. Wood P. A. Jahng W. J. Neuroprotective role of erythropoietin by antiapoptosis in the retina J Neurosci Res.2009 87 2365 2374 - 28.
Clark JI, Muchowski PJ, Small heat-shock proteins and their potential role in human disease, Curr. Opin. Struct. Biol.2000 10 52 59 - 29.
Coates P. J. Nenutil R. Mc Gregor A. Picksley S. M. Crouch D. H. Hall P. A. Wright E. G. Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence Exp Cell Res.2001 265 262 273 - 30.
Cottet S. Michaut L. Boisset G. Schlecht U. Gehring W. Schorderet D. F. Biological characterization of gene response in RPE65-/- mouse model of Leber’s congenital amaurosis during progression of the disease FASEB J.2006 20 2036 2049 - 31.
Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield, JG. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;12:14682-14687. - 32.
Dani C. Cecchi A. Bertini G. Role of oxidative stress as physiopathologic factor in the preterm infant. Minerva Pediatr.2004 56 381 394 - 33.
Davis, A.A., Bernstein P.S., Bok, D., Turner, J., Nachtigal, M., and Hunt, R.C. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest. Ophthalmol. Vis. Sci. 1995;36:955-964. - 34.
Decanini A. Karunadharma P. R. Nordgaard C. L. Feng X. Olsen T. W. Ferrington D. A. Human retinal pigment epithelium proteome changes in early diabetes 2007 51 1051 1061 - 35.
Deigner P. S. Law W. C. Canada F. J. Rando R. R. Membranes as the energy source in the endergonic transformation of vitamin A to 11-cis-retinol. Science1989 244 968 971 - 36.
den Engelsman J, Gerrits D, de Jong WW, Robbins J, Kato K, Boelens WC. Nuclear import of {alpha}B-crystallin is phosphorylation-dependent and hampered by hyperphosphorylation of the myopathy-related mutant R120G. J Biol Chem. 2005;280:37139-37148. - 37.
Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA, The proteome of central and peripheral retina with progression of age-related macular degeneration, Invest. Ophthalmol. Vis. Sci. 2006;47:2280-2290. - 38.
Felius J. Thompson D. A. Khan N. W. Bingham E. L. Jamison J. A. Kemp J. A. Sieving P. A. Clinical course and visual function in a family with mutations in the RPE65 gene. Arch. Ophthalmol.2002 120 55 61 - 39.
Gangalum RK, Atanasov IC, Zhou ZH, Bhat SP. AlphaB-crystallin is found in detergent-resistant membrane microdomains and is secreted via exosomes from human retinal pigment epithelial cells. J Biol Chem. 2011;286:3261-3269. - 40.
Genc S. Kuralay F. Genc K. Akhisaroglu M. Fadiloglu S. Yorukoglu K. Fadiloglu M. Gure A. Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci Lett2001 298 139 141 - 41.
Grimm C. Wenzel A. Hafezi F. Yu S. Redmond T. M. CE Reme Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nature Genet2000 25 63 66 - 42.
Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassman M, Reme CE. HIF-1 induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002;8:718-724. - 43.
Grune T. Reinheckel T. Davies K. J. Degradation of oxidized proteins in mammalian cells. FASEB J.1997 11 526 34 - 44.
Gu, S. M., Thompson, D.A., Srikumari, C.R., Lorenz, B., Finckh, U., Nicoletti, A., Murphy, K.R., Rathmann, M., Kumaramanickavel, G., Denton, M.J., and Gal, A. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat. Genetics 1997;17:194-197. - 45.
Haass C. Strooper B. D. The presenilins in Alzheimer’s disease-proteolysis holds the key. Science1999 286 916 919 - 46.
Ham DI, Gentleman S, Chan CC, McDowell JH, Redmond TM, Gery I. RPE65 is highly uveitogenic in rats. Invest Ophthalmol Vis Sci. 2002;43:2258-2263. - 47.
Hamel, C. P., Tsilou, E., Harris, E., Pfeffer, B. A., Hooks, J. J., Detrick, B., and Redmond, T. M. A developmentally regulated microsomal protein specific for the pigment epithelium of the vertebrate retina. J. Neuroscience Res. 1993a;34:414-425. - 48.
Hamel C. P. Tsilou E. Pfeffer B. A. Detrick B. Redmond T. M. Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J. Biol. Chem.1993b 268 15751 15757 - 49.
Reinal dystrophies caused by mutations in RPE65: assessment of visual functions. Br. J. Ophthalmol.Hamel C. P. Griffoin J. M. Lasquellec L. Bazalgette C. Arnaud B. 2001 85 424 427 - 50.
Hardeland R, Coto-Montes A, Poeggeler B. Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol Int. 2003;20:921-62. - 51.
Head KA. Natural therapies for ocular disorders, part one: diseases of the retina. Altern Med Rev.1999 Oct;4 5 342 59 - 52.
Hrushesky WJ. 1985 Circadian timing of cancer chemotherapy. Science228 73 5 - 53.
Hooks J. J. Detrick B. Percopo C. Hamel C. Siraganian R. P. Development and characterization of monoclonal antibodies directed against the retinal pigment epithelial cells Invest. Ophthalmol. Vis. Sci.1989 30 2106 2113 - 54.
Jahng W. J. Cheung E. Rando R. R. Lecithin retinol acyltransferase forms functional homodimers. 2002 41 20 6311 9 - 55.
Jahng WJ, David C, Nesnas N, Nakanishi K, Rando RR. A cleavable affinity biotinylating agent reveals a retinoid binding role for RPE65. Biochemistry. 2003a;42(20):6159-68. - 56.
Jahng W. J. Xue L. Rando R. R. Lecithin retinol acyltransferase is a founder member of a novel family of enzymes. 2003b 42 44 12805 12 - 57.
Jelkmann W. Metzen E. Erythropoietin in the control of red cell production. Ann Anat1996 178 391 403 - 58.
Jelkmann W. Effects of erythropoietin on brain function. Current Pharmaceutical Biotech2005 6 65 79 - 59.
Erythropoietin after a century of research: younger than ever. Eur J HaematolJelkmann W. 2007 78 183 205 - 60.
Jin, M., Li, S., Moghrabi, W.N., Sun, H. and Travis, G.H. Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell 2005;122:449-459. - 61.
Kanaan NM, Collier TJ, Marchionini DM, McGuire SO, Fleming MF, Sortwell CE. Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson’s disease Brain Res2006 1068 221 229 - 62.
Kapphahn RJ, Ethen CM, Peters EA, Higgins L, Ferrington DA, Modified alpha A crystallin in the retina: altered expression and truncation with aging, Biochemistry 2003;42:15310-15325. - 63.
Katsura Y. Okano T. Matsuno K. Osako M. Kure M. Watanabe T. Iwaki Y. Noritake M. Kosano H. Nishigori H. Matsuoka T. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. 2005 28 9 2252 4 - 64.
Erythropoietin receptor-mediate d inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol ChemKawakami M. Sekiguchi M. Sato K. Kozaki S. Takahashi M. 2001 276 39469 39475 - 65.
Kim, SR., Fishkin, N., Kong, J., Nakanishi, K., Allikmets, R., and Sparrow, J. R. Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E. 2004;101:11668-11672. - 66.
Kim T. Kim S. J. Kim K. Kang U. B. Lee C. Park K. S. Yu H. G. Kim Y. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. 2007 7 4203 4215 - 67.
Kim YH, Choi MY, Kim YS, Han JM, Lee JH, Park CH, Kang SS, Choi WS, Cho GJ, Protein kinase C delta regulates anti-apoptotic alphaB-crystallin in the retina of type 2 diabetes, Neurobiol. Dis. 2007;28:293-303. - 68.
Kloer D. P. Ruch S. Al-Babili S. Beyer P. Schulz G. E. The structure of a retinal-forming carotenoid oxygenase. Science2005 308 267 269 - 69.
Kolonin M. G. Saha P. K. Chan L. Pasqualini R. Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med.2004 10 625 632 - 70.
Kretz A. Happold C. J. Martick J. K. Isenmann S. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci2005 29 569 579 - 71.
Lee H. Chung H. Arnouk H. Lamoke F. Hunt R. C. Hrushesky W. J. Wood P. A. Lee S. H. Jahng W. J. Cleavage of the retinal pigment epithelium-specific protein RPE65 under oxidative stress Int J Biol Macromol.2010a 47 104 108 - 72.
Lee H. Arnouk H. Sripathi S. Chen P. Zhang R. Hunt R. C. Hrushesky W. J. Chung H. Lee S. H. Jahng W. J. Prohibitin as an oxidative stress biomarker in the eye Int J Biol Macromol.2010b 47 685 690 - 73.
Lee H. Chung H. Lee S. H. Jahng W. J. Light-induced phosphorylation of crystallins in the retinal pigment epithelium Int J Biol Macromol.2011 48 194 201 - 74.
Lee HC, Yin PH, Lu CY, Chi CW, Wei YH. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem J.2000 348 425 32 - 75.
Li Y. Lu Z. Keogh C. L. Yu S. P. Wei L. 2007 Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J. Cereb. Blood. Flow Metab. 2007;27 1043 1054 - 76.
Liu X. Shen J. Jin Y. Duan M. Xu J. 2006 Recombinant human erythropoietin (rhEPO) preconditioning on nuclear factor-kappa B (NF-kB) activation & proinflammatory cytokines induced by myocardial ischaemi a-reperfusion Indian J Med Res124 343 354 - 77.
Ma, J-x., Zhang, J., Othersen, K. L., Moiseyev, G., Ablonczy, Z., Redmond, T. M., Chen, Y., Crouch, R. K. Expression, purification, and MALDI analysis of RPE65. Invest. Ophthalmol. Vis. Sci. 2001;42:1429-1435. - 78.
Madigan MC, Penfold PL, Provis JM, Balind TK, Billson FA. Intermediate filament expression in human retinal macroglia. Histopathologic changes associated with age-related macular degeneration. Retina. 1994;14(1):65-74. - 79.
Martinon, F., and Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004;117:561-574. - 80.
Mata NL, Moghrabi WN, Lee JS, Bui TV, Radu RA, Horwitz J, Travis GH. Rpe65 is a retinyl ester binding protein that presents insoluble substrate to the isomerase in retinal pigment epithelial cells. J. Biol. Chem. 2004;279:635-643. - 81.
Mauer AM. Diurnal variation of proliferative activity in the human bone marrow. 1965 26 1 7 - 82.
Mc Clung J. K. Danner D. B. Stewart D. A. Smith J. R. Schneider E. L. Lumpkin C. K. Dell’Orco R. T. Nuell M. J. Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem. Biophys. Res. Commun.1989 164 1316 1322 - 83.
McClung JK, Jupe ER, Liu XT, Dell’Orco RT. Prohibitin: potential role in senescence, development, and tumor suppression. Exp Gerontol.1995 30 99 124 - 84.
Melov S. Coskun P. Patel M. Tuinstra R. Cottrell B. AS Jun Zastawny. T. H. Dizdaroglu M. Goodman S. I. Huang T. T. Miziorko H. Epstein C. J. Wallace D. C. Mitochondrial disease in superoxide dismutase 2 mutant mice Proc Natl Acad Sci U S A.1999 96 846 51 - 85.
Miyake T. Kung C. K. H. Goldwasser E. Purification of human erythropoietin. J Biol Chem1977 252 5558 5564 - 86.
Morishita E. Masuda S. Nagao M. Yasuda Y. Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. 1997 76 105 116 - 87.
Morita M. Ohneda O. Yamashita T. Takahashi S. Suzuki N. Nakajima O. Kawauchi S. Ema M. Shibahara S. Udono T. Tomita K. Tamai M. Sogawa K. Yamamoto M. Fujii-Kuriyama Y. H. L. F. H. I. HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J2003 22 1134 1146 - 88.
Moiseyev, G., Chen, Y., Takahashi, Y., Wu, B.X. and Ma, J.-x. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc. Natl. Acad. Sci. USA. 2005;102:12413-12418. - 89.
Nikolaeva O, Takahashi Y, Moiseyev G, Ma JX. Purified RPE65 shows isomerohydrolase activity after reassociation with a phospholipid membrane. FEBS J. 2009;276:3020-3030 - 90.
Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J.Nijtmans L. G. de Jong L. Artal Sanz. M. Coates P. J. Berden J. A. Back J. W. Muijsers A. O. van der Spek H. Grivell L. A. 2000 19 2444 2451 - 91.
Nijtmans LG, Artal SM, Grivell LA, Coates PJ. The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol Life Sci.2002 59 143 55 - 92.
Nordgaard CL, Berg KM, Kapphahn RJ, Reilly C, Feng X, Olsen TW, Ferrington DA, Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration, Invest. Ophthalmol. Vis. Sci. 2006;47:815-822. - 93.
Nordgaard C. L. Karunadharma P. P. Feng X. Olsen T. W. Ferrington D. A. Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration Invest Ophthalmol Vis Sci.2008 49 2848 55 - 94.
Nuell MJ, Stewart DA, Walker L, Friedman V, Wood CM, Owens GA, Smith JR, Schneider EL, Dell’ Orco R, Lumpkin CK, et al. Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol. 1991;11:1372-81. - 95.
Organisciak D. Darrow R. Barsalou L. Rapp C. Mc Donald B. Wong P. Light induced and circadian effects on retinal photoreceptor cell crystallins. Photochem Photobiol.2011 87 151 159 - 96.
Osborne N. N. Ugarte M. Chao M. Chidlow G. Bae J. H. Wood J. P. MS Nash Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol.1999 Suppl 1:S102 28 - 97.
Rando R. R. The biochemistry of the visual cycle. Chem. Rev.2001 101 1881 1896 - 98.
Redmond, T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J.-x., Crouch, R. K., Pfeifer, K. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nature Genet. 1998;20:344-351. - 99.
Redmond T. M. Poliakov E. Shirley Y. Tsai J. Y. Lu Z. Gentleman S. Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle Proc. Natl. Acad. Sci. USA.2005 102 13658 13663 - 100.
Rivera-Milla E. Stuermer C. A. Málaga-Trillo E. Ancient origin of reggie (flotillin), reggie-like, and other lipid-raft proteins: convergent evolution of the SPFH domain. Cel.l Mol. Life Sci.2006 63 343 357 - 101.
Saari J. C. Biochemistry of visual pigment regeneration. Invest. Ophthalmol. Vis. Sci.2000 41 337 348 - 102.
Sakaguchi H, Miyagi M, Darrow RM, Crabb JS, Hollyfield JG, Organisciak DT, Crabb JW, Intense light exposure changes the crystallin content in retina, Exp. Eye. Res. 2003;76:131-133. - 103.
Santoro M. F. Annand R. R. MM Robertson Peng. Y. W. MJ Brady Mankovich. J. A. Hackett M. C. Ghayur T. Walter G. Wong W. W. Giegel D. A. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J Biol Chem.1998 273 13119 13128 - 104.
Satici A. Guzey M. Gurler B. Vural H. Gurkan T. Malondialdehyde and antioxidant enzyme levels in the aqueous humor of rabbits in endotoxin-induced uveitis Eur J Ophthalmol.2003 Nov-Dec;13(9-10):779 EOF - 105.
Scheving L. Tsai T. Sothern R. Hrushesky W. 1988 Circadian susceptibility-resistance cycles to radiation and their manipulability by methylene blue a non-toxic, in vivo oxidation-reduction complex). Pharmacology and Therapeutics 1988;39 397 402 - 106.
Schlunck G, Martin G, Agostini HT, Camatta G, Hansen LL. Cultivation of retinal pigment epithelial cells from human choroidal neovascular membranes in age related macular degeneration. Exp Eye Res. 2002;74:571-6. - 107.
N-acetylcysteine improves lysosomal function and enhances the degradation of photoreceptor outer segments in cultured RPE cells. Klin Monatsbl Augenheilkd.Schütt F. Völcker H. E. Dithmar S. 2007 224 580 584 - 108.
Schweizer U. Gunnersen J. Karch C. Wiese S. Holtmann B. Takeda K. Akira S. Sendtner M. Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult J Cell Biol2002 156 287 297 - 109.
Shang F. Taylor A. Function of the ubiquitin proteolytic pathway in the eye. Exp. Eye Res.2004 78 1 14 - 110.
Sharma A. Qadri A. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses Proc Natl Acad Sci U S A.2004 101 17492 17497 - 111.
Singh A. K. Szczech L. Tang K. L. Barnhart H. Sapp S. Wolfson M. Reddan D. Investigators C. H. O. I. R. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med.2006 355 20 2085 98 - 112.
Sitte N. Huber M. Grune T. Ladhoff A. Doecke W. D. Von Zglinicki. T. Davies K. J. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J.2000 14 1490 8 - 113.
Smaaland R, Laerum OD, Lote K, et al. DNA synthesis in human bone marrow is circadian stage dependent. Blood 1991;77: 2603-2611. - 114.
Smaaland R, Abrahamsen JF, Svardal AM, Lote K, Ueland PM. DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients. Br J Cancer. 1992 Jul;66(1):39-45. - 115.
Spector A. Oxidative stress-induced. cataract mechanism. of action. F. A. S. E. B. J. 1995 Sep;9 12 1173 82 - 116.
Spraul CW, Lang GE, Grossniklaus HE. Morphometric analysis of the choroid, Bruch’s membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci1996 37 2724 35 - 117.
Sreekumar PG, Kannan R, Kitamura M, Spee C, Barron E, Ryan SJ, Hinton DR. alphaB crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells. PLoS One. 2010;5:e12578. - 118.
Sripathi S. R. He W. Atkinson C. L. Smith J. J. Liu Z. BM Elledge Jahng. W. J. Mitochondrial Mitochondrial-Nuclear Communication by Prohibitin Shuttling under Oxidative Stress 2011 50 8342 51 - 119.
Stecher H. Gelb M. H. Saari J. C. Palczewski K. Preferential release of 11-cis-retinol from retinal pigment epithelial cells in the presence of cellular retinaldehyde-binding protein. J Biol Chem.1999 274 8577 85 - 120.
Steglich G. Neupert W. Langer T. Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. Mol Cell Biol.1999 19 3435 3442 - 121.
Strauss O. The retinal pigment epithelium in visual function. Physiol. Rev.2005 85 845 881 - 122.
Taniguchi CM, Emanuelli B, Kahn CR, Critical nodes in signalling pathways: insights into insulin action, Nat. Rev. Mol. Cell. Biol. 2006;7:85-96. - 123.
Tao WA, Wollscheid B, O’Brien R, Eng JK, Li XJ, Bodenmiller B, Watts JD, Hood L, Aebersold R, Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry, Nat. Methods. 2005;2:591-598. - 124.
Tezel G. Yang X. Cai J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest Ophthalmol Vis Sci.2005 46 3177 3187 - 125.
Travis G. H. Golczak M. Moise A. R. Palczewski K. Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. Annu. Rev. Pharmocol. Toxicol.2007 1 8 - 126.
JJ, Kertesz N, Groszer M, Matter C, Gao J, Liu X, Wu H, Carmichael ST.Tsai P. T. Ohab J. J. Kertesz N. Groszer M. Matter C. Gao J. Liu X. Wu H. Carmichael S. T. A. critical role. of erythropoietin. receptor in. neurogenesis post-stroke recovery. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci2006 1269 1274 - 127.
Tsilou, E., Hamel, C. P., Yu, S., and Redmond, T. M. RPE65, the major retinal pigment epithelium microsomal membrane protein, associates with phospholipids liposomes. Arch. Biochem. Biophys. 1997;346:21-27. - 128.
Wang S. Nath N. Fusaro G. Chellappan S. Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals Mol Cell Biol.1999b 19 7447 60 - 129.
Wang S. Fusaro G. Padmanabhan J. Chellappan S. P. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. 2002 21 8388 8396 - 130.
Warburton S. Davis W. E. Southwick K. Xin H. Woolley A. T. Burton G. F. Thulin C. D. Proteomic and phototoxic characterization of melanolipofuscin: correlation to disease and model for its origin Mol Vis.2007 13 318 329 - 131.
Watanabe D. Suzuma K. Matsui S. Kurimoto M. Kiryu J. Kita M. Suzuma I. Ohashi H. Ojima T. Murakami T. Kobayashi T. Masuda S. Nagao M. Yoshimura N. Takagi H. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med.2005 353 8 782 92 - 132.
Weishaupt J. H. Rohde G. Pölking E. Siren A. L. Ehrenreich H. Bähr M. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci2004 45 1514 1522 - 133.
Wenzel A. Grimm C. Samardzija M. CE Reme Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retinal Eye Res2005 24 275 306 - 134.
West KA, Yan L, Miyagi M, Crabb JS, Marmorstein AD, Marmorstein L, Crabb JW. Proteome survey of proliferating and differentiating rat RPE-J cells. Exp Eye Res. 2001 Oct;73(4):479-91. - 135.
Wood P. A. Hrushesky W. J. M. Klevecz R. 1998 Distinct circadian time structures characterize myeloid and erythroid progenitor and multiprogenitor clonogenicity as well as marrow precursor proliferation dynamics. Exp Hematol26 523 533 - 136.
Xi J, Farjo R, Yoshida S, Kern TS, Swaroop A, Andley UP, A comprehensive analysis of the expression of crystallins in mouse retina, Mol. Vis. 2003;28:410-419. - 137.
Xue L, Gollapalli DR, Maiti P, Jahng WJ, Rando RR. A palmitoylation switch mechanism in the regulation of the visual cycle. Cell. 2004;117(6):761-71. - 138.
Xue L. Jahng W. J. Gollapalli D. Rando R. R. Palmitoyl transferase activity of lecithin retinol acyl transferase. 2006 45 35 10710 8 - 139.
Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A. 1997;94:514-9. - 140.
Yamaji R. Okada T. Moriya M. Naito M. Tsuruo T. Miyatake K. Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA Eur. J. Biochem.1996 239 494 500 - 141.
Yang P, Peairs JJ, Tano R, Jaffe GJ, Oxidant-mediated Akt activation in human RPE cells, Invest. Ophthalmol. Vis. Sci. 2006;47:4598-4606. - 142.
Yen S. H. Gaskin F. Fu S. M. Neurofibrillary tangles in senile dementia of the Alzheimer type share an antigenic determinant with intermediate filaments of the vimentin class. Am J Pathol.1983 113 373 381 - 143.
Yu K. R. Hijikata T. Lin Z. X. Sweeney H. L. Englander S. W. Holtzer H. Truncated desmin in PtK2 cells induces desmin-vimentin-cytokeratin coprecipitation, involution of intermediate filament networks, and nuclear fragmentation: a model for many degenerative diseases. Proc Natl Acad Sci U S A.1994 91 2497 2501 - 144.
Zhang R. Hrushesky W. J. Wood P. A. Lee S. H. Hunt R. C. Jahng W. J. Melatonin reprogrammes proteomic profile in light-exposed retina in vivo Int J Biol Macromol.2010 47 255 60 - 145.
Zhong L. Bradley J. Schubert W. Ahmed E. Adamis A. P. Shima D. T. Robinson G. S. Ng Y. S. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci.2007 48 3 1212 8 - 146.
Zhou H, Ye H, Dong J, Han G, Jiang X, Wu R, Zou H, Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis, J. Proteome. Res. 2008;7:3957-3967. - 147.
Mutation in the βA3/AZigler J. S. Jr Zhang C. Grebe R. Sehrawat G. Hackler L. Jr Adhya S. Hose S. DS Mc Leod Bhutto. I. Barbour W. Parthasarathy G. Zack D. J. Sergeev Y. Lutty G. A. Handa J. T. Sinha D. 1 crystallin gene impairs phagosome degradation in the retinal pigmented epithelium of the rat. J Cell Sci.2011 Pt 4):523-531. - 148.
Zimmermann MB, Biebinger R, Rohner F, Dib A, Zeder C, Hurrell RF, Chaouki N. Vitamin A supplementation in children with poor vitamin A and iron status increases erythropoietin and hemoglobin concentrations without changing total body iron. Am J Clin Nutr 2006;84:80-586.